Asia Pacific Vitrectomy Devices Market Key Players and Opportunities by 2028

Asia Pacific Vitrectomy Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product ( Vitrectomy Accessories, Vitrectomy Machines, Microscopic Illumination Equipment, Surgical Instruments, and Others ), Application ( Diabetic Retinopathy, Retinal Detachment, Epiretinal Membrane, Macular Hole, and Others ), Patient Type ( Adult, Pediatrics, and Geriatric ), Surgery Approach ( Posterior/Pars Plana Vitrectomy, and Anterior Vitrectomy ), End User ( Hospitals, Ophthalmology Clinics, and Ambulatory Surgery Centers (ASCs) ), Distribution channel ( Direct tenders, Third party distributors, and Retail sales)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028
  • Status : Published
  • Report Code : TIPRE00026813
  • Category : Life Sciences
  • No. of Pages : 209
  • Available Report Formats : pdf-format excel-format
Buy Now
Asia Pacific Vitrectomy Devices Market Key Players and Opportunities by 2028
Report Date: Jan 2022   |   Report Code: TIPRE00026813 Email: sales@theinsightpartners.com
Buy Now

The Asia Pacific vitrectomy devices market is expected to reach US$ 408.9 million by 2028 from US$ 250.6 million in 2021. The market is estimated to grow at a CAGR of 7.2% from 2021–2028.


The rising demand for cataract, refractive, and vitrectomy surgeries is expected to increase the sales of vitrectomy devices. Leading market players are increasing their penetration across emerging markets by expanding their distribution networks and augmented manufacturing capabilities. Emerging markets are expected to offer potential growth opportunities for key vitrectomy device manufacturers in the years to come. This can be attributed to the large patient population, high prevalence of eye diseases, such as cataracts and other vision impairments, increasing disposable income, improving healthcare infrastructure, and growing medical tourism in these countries. High investments in life science and health research in emerging countries play a key role in upgrading the latest technologies in these countries. This factor, in turn, supports the inclination toward vitrectomy surgeries.

Countries such as Japan and Australia are conducting virtual international conferences to anticipate the impact of COVID-19 on medical device industry in the Asia Pacific. The ongoing COVID-19 pandemic has created a seismic shift in living habits in the region and medical device industry has borne a significant brunt of this shopper shake-up. China is specifically facing issues with the pandemic, leading to disruption of the supply chain, projected losses in revenue, marketing and sales within all industries, as well as the concerns of health within the production units and other public places. On the other hand, unlike to North America and Europe as of now Asian countries have not imposed second lockdown. Hence, the businesses in the countries are slowly recovering their economies. Urban areas are experiencing adjusting to a changing market. Thus, owing to these it is likely to have opportunities for the market to bring its economy on track.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the vitrectomy devices market. The Asia Pacific vitrectomy devices market is expected to grow at a good CAGR during the forecast period.

Asia Pacific Vitrectomy Devices Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Vitrectomy Devices Market Revenue and Forecast to 2028 (US$ Million)

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Asia Pacific Vitrectomy Devices Market Segmentation

By Product

  • Vitrectomy Machines
  • Vitrectomy Accessories
  • Microscopic Illumination Equipment
  • Surgical Instruments
  • Others

By Patient Type

  • Geriatric
  • Adult
  • Pediatrics

By Surgery Approach

  • Posterior/Pars Plana Vitrectomy
  • Anterior Vitrectomy

By Application

  • Diabetic Retinopathy
  • Retinal Detachment
  • Epiretinal Membrane
  • Macular Hole
  • Others

By End User

  • Hospitals
  • Ophthalmology Clinics
  • Ambulatory Surgery Centers (ASCs)

By Distribution Channel

  • Retail Sales
  • Direct Tenders
  • Third Party Distributors Retinal

By Country

  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

Companies Mentioned

  • D.O.R.C Dutch Ophthalmic Research Center (International)B.V          
  • HOYA Corporation     
  • NIDEK CO., LTD       
  • Danaher(Leica Microsystems AG)             
  • Carl Zeiss Meditec    
  • Alcon Inc.      
  • Iridex Corporation    
  • Bausch Health Companies Inc.          
  • Topcon Corporation            
  • Optos
  • GEUDER AG         

Asia Pacific Vitrectomy Devices Report Scope

Report Attribute Details
Market size in 2021 US$ 250.6 Million
Market Size by 2028 US$ 408.9 Million
CAGR (2021 - 2028) 7.2%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Vitrectomy Accessories
  • Vitrectomy Machines
  • Microscopic Illumination Equipment
  • Surgical Instruments
By Application
  • Diabetic Retinopathy
  • Retinal Detachment
  • Epiretinal Membrane
  • Macular Hole
  • Others
By Patient Type
  • Adult
  • Pediatrics
  • Geriatric
By Surgery Approach
  • Posterior/Pars Plana Vitrectomy
  • Anterior Vitrectomy
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • D.O.R.C Dutch Ophthalmic Research Center (International) B.V
  • HOYA Corporation
  • NIDEK CO., LTD
  • Danaher (Leica Microsystems AG)
  • Carl Zeiss Meditec
  • Alcon Inc.
  • Iridex Corporation
  • Bausch Health Companies Inc.
  • Topcon Corporation
  • Optos
  • GEUDER AG
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
☀️ Eligible for Summer Discount
Unlock Exclusive Report Discounts
Enquire Now
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA
Page Updated: Feb 2022